Vietnamese-American nurse Nina Pham has been cured of Ebola.

Health officials in the US state of Texas announced that Vietnamese-American nurse Nina Pham has been cured of Ebola and will be discharged from the hospital on October 24.

The medical treatment center in Bethesda, Maryland where Nina Pham is being treated said it will hold a press conference to discuss details of the nurse's case at 11:30 local time (22:30 Vietnam time).

US President Barack Obama receives nurse Nina Pham at the White House after she was declared Ebola-free (Source: AP)

Nina Pham is the first case of Ebola infection in the United States. She and nurse Amber Vinson were infected with Ebola while treating patient Thomas Duncan, a Liberian who died on October 8 in the United States. Amber Vinson is currently being treated at Emory University Hospital in Atlanta.

On October 24, the US also confirmed another case of Ebola, Dr. Craig Spencer, who returned after treating Ebola patients in Guinea.

Regarding efforts to contain the epidemic, on October 24, Chinese President Xi Jinping announced that he would provide about 82 million USD in aid to West African countries heavily affected by this dangerous virus, including Liberia, Sierra Leone and Guinea.

Xi Jinping said China will provide cash and material aid, send medical experts and staff, and help build treatment centers in Liberia.

Earlier the same day, leaders of European Union (EU) member states agreed to increase aid to West Africa to 1 billion euros (1.26 billion USD) to deal with the Ebola epidemic.

Meanwhile, the World Health Organization (WHO) said that Ebola vaccine trials could begin in West Africa in December, with hundreds of thousands of doses of the vaccine being widely used in the first half of 2015.

Speaking after a meeting between WHO and officials, health experts, government officials from countries affected by the Ebola outbreak as well as pharmaceutical companies and donors, WHO Assistant Director-General Marie-Paule Kieny said the two upcoming experimental vaccines are rVSV developed by the National Microbiology Laboratory of Canada and ChAd3 produced by British pharmaceutical company GlaxoSmithKline. Currently rVSV has begun testing in the US, and is expected to be tested in Switzerland, Germany, Gabon and Kenya.

Meanwhile, ChAd3 is being tested in the US, UK and Mali, and will continue to be tested in Switzerland. WHO staff are encouraged to test the vaccine. Five other potential vaccines, provided by the UK and Russia, will be tested in the first months of 2015.

The latest figures released by the WHO show that the Ebola epidemic has killed 4,555 people out of 9,216 cases of infection. Liberia, Sierra Leone, and Guinea are the West African countries most severely affected by this epidemic./.

According to VNA